South Dakota Chronicle

Profacgen Released Coronavirus Service Platform for Research

 Breaking News
  • No posts were found

Profacgen Released Coronavirus Service Platform for Research

February 28
03:21 2020
In an effort to help further scientific research in coronavirus, Profacgen released a novel coronavirus service platform.

Recently, Coronavirus disease 2019 (COVID-19) infection quickly broke out in China and spread to many countries. In an effort to help further scientific research in coronavirus, Profacgen released a novel coronavirus service platform.

The outbreak of pneumonia caused by the COVID-19 was first occurred in Wuhan, China in December 2019, and then COVID-19 infection quickly broke out in China and spread to many countries including the United States. COVID-19 infection may cause severe symptoms of acute respiratory infections and even develop into acute respiratory distress syndrome (ARDS), present a significant threat to human life.

Coronaviruses as members of the subfamily Coronavirinae belong to the virus family Coronaviridae, which is the largest enveloped positive-sense RNA viruses. The subfamily Coronavirinae can be divided into four genera according to its genomic structure and their phylogenetic relationships, which are Alphacoronavirus, Betacoronavirus, Gammacoronavirus and Deltacoronavirus.

Now, Profacgen provides viral protein-related services including protein expression services, protein interaction analysis services, enzyme activity assay, computational protein analysis and virtual screening to satisfy different needs in the research about coronavirus.

“At this urgent stage, coronavirus-related research is of great significance in the fields of public health and epidemiology. Our professional and high-quality technical services are committed to helping further your research in coronavirus. And hope this war will end soon and the life would be regular as soon as possible,” commented Crystal, the chief marketing staff in Profacgen.

To get more information about the Coronavirus Service Platform from Profacgen, please visit https://www.profacgen.com/coronavirus-service-platform.

About Profacgen

Profacgen provides process development and cGMP manufacturing services for biological active ingredients. We have ready access to state-of-the-art biopharmaceutical product development and manufacturing facilities and our staff scientists have demonstrable expertise in all aspects of biopharmaceutical manufacturing, from facility design and operation to the ability to provide best advice relating to product development.

Media Contact
Company Name: Profacgen
Contact Person: Ellen Burns
Email: Send Email
Phone: 1-631-619-7922
Country: United States
Website: https://www.profacgen.com